Phillips David P, Barker Gwendolyn E C, Eguchi Megan M
Department of Sociology 0533, University of California at San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0533, USA.
Arch Intern Med. 2008 Jul 28;168(14):1561-6. doi: 10.1001/archinte.168.14.1561.
Increasingly, medications are consumed outside of clinical settings, with relatively little professional oversight. Despite this trend, previous studies of medication errors have focused on clinical settings.
We examined all US death certificates from January 1, 1983, to December 31, 2004 (N = 49,586,156), particularly those with fatal medication errors (FMEs) (n = 224,355). We examined trends in 4 types of FMEs that vary according to the relative importance of alcohol/street drugs and the relative likelihood of professional oversight in the consumption of medications.
The overall FME death rate increased by 360.5% (1983-2004). This increase far exceeds the increase in death rates from adverse effects of medications (33.2%) or from alcohol and/or street drugs (40.9%). The increase in FMEs varies markedly by type. Type 1 (domestic FMEs combined with alcohol and/or street drugs) shows the largest increase (3196%). In contrast, type 4 (nondomestic FMEs not involving alcohol and/or street drugs) shows the smallest increase (5%). Types 2 and 3 show intermediate increases. Type 2 (domestic FMEs not involving alcohol and/or street drugs) increased by 564%. Type 3 (nondomestic FMEs combined with alcohol and/or street drugs) increased by 555%. Thus, domestic FMEs combined with alcohol and/or street drugs have become an increasingly important health problem compared with other FMEs.
These findings suggest that a shift in the location of medication consumption from clinical to domestic settings is linked to a steep increase in FMEs. It may now be possible to reduce FMEs by focusing not only on clinical settings but also on domestic settings.
越来越多的药物是在临床环境之外服用的,专业监督相对较少。尽管有这种趋势,但先前关于用药错误的研究主要集中在临床环境。
我们检查了1983年1月1日至2004年12月31日期间所有的美国死亡证明(N = 49,586,156),特别是那些有致命用药错误(FME)的证明(n = 224,355)。我们研究了4种类型的FME的趋势,这些类型根据酒精/街头毒品的相对重要性以及用药过程中专业监督的相对可能性而有所不同。
FME的总体死亡率上升了360.5%(1983 - 2004年)。这一增长远远超过了药物不良反应死亡率的增长(33.2%)或酒精和/或街头毒品死亡率的增长(40.9%)。FME的增长因类型而异,差异显著。类型1(家庭FME与酒精和/或街头毒品相结合)增长幅度最大(3196%)。相比之下,类型4(非家庭FME,不涉及酒精和/或街头毒品)增长幅度最小(5%)。类型2和类型3增长幅度居中。类型2(不涉及酒精和/或街头毒品的家庭FME)增长了564%。类型3(非家庭FME与酒精和/或街头毒品相结合)增长了555%。因此,与其他FME相比,家庭FME与酒精和/或街头毒品相结合已成为一个日益重要的健康问题。
这些发现表明,用药地点从临床环境向家庭环境的转变与FME的急剧增加有关。现在,不仅关注临床环境,还关注家庭环境,可能有助于减少FME。